Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Illumina, Inc. - Common Stock
(NQ:
ILMN
)
128.96
+0.93 (+0.73%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 5, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Illumina, Inc. - Common Stock
< Previous
1
2
...
29
30
31
32
33
34
35
36
Next >
Illumina Donates $1 Million in Sequencing Capabilities to Mumbai to Support Sequencing-Based COVID-19 Surveillance in India
August 04, 2021
Illumina Donates $1 Million in Sequencing Capabilities to Mumbai to Support Sequencing-Based COVID-19 Surveillance in India
Via
News Direct
Illumina Donates $1 Million in Sequencing Capabilities to Mumbai to Support Sequencing-Based COVID-19 Surveillance in India
August 04, 2021
SOURCE: Illumina
Via
3BL Media
What We Learned About Genetic Sequencing During COVID-19 Could Revolutionize Public Health
August 02, 2021
What We Learned About Genetic Sequencing During COVID-19 Could Revolutionize Public Health
Via
News Direct
What We Learned About Genetic Sequencing During COVID-19 Could Revolutionize Public Health
August 02, 2021
SOURCE: Illumina
Via
3BL Media
Illumina Celebrates National Intern Day
July 30, 2021
SOURCE: Illumina
Via
3BL Media
DNA Sequencing Instruments Market to See Huge Growth by 2026 : Abbott Laboratories, Agilent Technologies, Danaher
↗
August 04, 2021
Stay up to date with DNA Sequencing Instruments Market research offered by AMA. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Proteomics Market worth $55.9 billion by 2026
August 02, 2021
Via
AB Newswire
Illumina Celebrates National Intern Day
July 30, 2021
Illumina Celebrates National Intern Day
Via
News Direct
3 Things About Illumina That Smart Investors Know
↗
July 30, 2021
The company is cemented as the industry leader, but a crack is showing.
Via
The Motley Fool
After Naming a New CFO, Is This Genetic Diagnostics Company a Buy?
↗
July 29, 2021
Veracyte appointed Rebecca Chambers, who boasts a wealth of financial executive experience, to the position.
Via
The Motley Fool
Illumina to Webcast Upcoming Investor Conference
July 28, 2021
From
Illumina, Inc.
Via
Business Wire
Illumina Employees are Encouraged to Invest in Themselves With Annual Health and Lifestyle Allowance
July 27, 2021
Illumina Employees are Encouraged to Invest in Themselves With Annual Health and Lifestyle Allowance
Via
News Direct
Illumina Employees are Encouraged to Invest in Themselves With Annual Health and Lifestyle Allowance
July 27, 2021
SOURCE: Illumina
Via
3BL Media
Illumina-Grail $8B Merger Hit By European Commission's In-Depth Investigation
↗
July 23, 2021
The European Commission has opened an in-depth, three-month investigation into Illumina Inc's (NASDAQ: ILMN) planned takeover of Grail, a deal valued...
Via
Benzinga
The Branford Group to Conduct Auction of Leading Genomic Testing Lab CQuentia in Memphis
July 23, 2021
The Branford Group ("Branford"), a leader in asset valuation and disposition services, has been engaged by CQuentia to sell the assets of its genomic testing and personalized healthcare facility in...
Via
Newswire.com
Topics
Intellectual Property
Illumina is Committed to Bringing Lifesaving GRAIL Test to People Globally as European Review Process Enters Second Phase
July 22, 2021
From
Illumina, Inc.
Via
Business Wire
The Vaccination of an Entire City in Brazil
July 22, 2021
How the Butantan Institute helped vaccinate the city of Serrana—and what they learned thereafter
Via
News Direct
Topics
Death
The Vaccination of an Entire City in Brazil
July 22, 2021
SOURCE: Illumina
Via
3BL Media
Topics
Death
Illumina Wins Reddot 2021 Award: Genomic Sequencing System NextSeq 1000/2000
July 20, 2021
Illumina Wins Reddot 2021 Award: Genomic Sequencing System NextSeq 1000/2000
Via
News Direct
Illumina Wins Reddot 2021 Award: Genomic Sequencing System NextSeq 1000/2000
July 20, 2021
SOURCE: Illumina
Via
3BL Media
Delta Defeats Bulls
↗
July 19, 2021
Stocks tended to crash without rhyme or reason.
Via
Talk Markets
Best And Worst Performances Of The Week
↗
July 18, 2021
Last week saw US indexes fall along with those of many European countries. However, Japan, Hong Kong, and Chinese markets all rose.
Via
Talk Markets
Illumina Partners With Arab Health in Neonatal and Pediatric Intensive Care Settings
July 15, 2021
Illumina Partners With Arab Health in Neonatal and Pediatric Intensive Care Settings
Via
News Direct
Illumina Partners With Arab Health in Neonatal and Pediatric Intensive Care Settings
July 15, 2021
SOURCE: Illumina
Via
3BL Media
Apple And Qualcomm Lead The QQQ Higher Wednesday
↗
July 14, 2021
U.S. indices were trading higher Wednesday as investors weigh comments from Fed Chair Powell. Strength in Apple Inc (NASDAQ:
Via
Benzinga
Topics
Economy
Illumina, Grail Merger Faces Full-Scale European Probe Amid Antitrust Concerns: Reuters
↗
July 14, 2021
The proposed $8 billion merger between liquid biopsy firm Grail Inc and cancer blood screening firm Illumina Inc (NASDAQ: ILMN) has met with nothing but flack...
Via
Benzinga
Bioinformatics Services Market Worth $5.3 Billion by 2026 - Exclusive Report by MarketsandMarkets™
↗
July 14, 2021
The bioinformatics services market is projected to reach $5.3 Billion by 2026. Bioinformatics analysis market report provides crucial industry insights that will help your business grow.
Via
SBWire
Is Illumina a Buy?
↗
July 14, 2021
Illumina has gained almost 29% this year and could be headed higher.
Via
The Motley Fool
Illumina to Announce Second Quarter 2021 Financial Results on Thursday, August 5, 2021
July 13, 2021
From
Illumina, Inc.
Via
Business Wire
Revolutionizing Forensics with Illumina’s Next-Generation Sequencing Technology
July 13, 2021
Othram, Inc. and the NovaSeq help convert more cases from cold to solved
Via
News Direct
Topics
Death
< Previous
1
2
...
29
30
31
32
33
34
35
36
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.